Scala Biodesign launches with $5.5M to develop bioproducts f

The company's computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.

Related Keywords

Israel , Israeli , Ravit Netzer , Scala Biodesign , Adi Goldenzweig , Weizmann Institute Of Science , Google , Tel Aviv Based , Weizmann Institute ,